Trial Profile
A study to evaluate the efficacy of tocilizumab one vial (400mg) per body infusion in patients with active rheumatoid arthritis - Oviboto study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate; Prednisolone
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms OVIBOTO
- 22 Jul 2015 New trial record